REG - Target Healthcare - Publication of Supplementary Prospectus

Target Healthcare ReitAnnouncement

15/10/2018 18:10

RNS Number : 1127E
Target Healthcare REIT Limited
15 October 2018
 


TARGET HEALTHCARE REIT LIMITED 
15 OCTOBER 2018
PUBLICATION OF SUPPLEMENTARY PROSPECTUS
Target Healthcare REIT Limited (the "Company") has today published a supplementary prospectus approved by the UK Listing Authority. The publication of the supplementary prospectus is a regulatory requirement under the Prospectus Rules following the publication of the Company's annual accounts for the year ended 30 June 2018.
The supplementary prospectus is supplemental to, and should be read in conjunction with, the prospectus published by the Company on 1 February 2018 in relation to the issue of ordinary shares pursuant to an initial placing, offer for subscription, open offer and placing programme.
A copy of the supplementary prospectus will shortly be available for inspection at the National Storage Mechanism which is located at http://www.morningstar.co.uk/uk/NSM
The supplementary prospectus is also available in electronic form on the Company's website at www.targethealthcarereit.co.uk and available for collection during normal business hours on any day (Saturday, Sunday and public holidays excepted) until 31 January 2019 at the offices of Dickson Minto W.S., Broadgate Tower, 20 Primrose Street, London EC2A 2EW.
 




Target Fund Managers Limited


 


 




Kenneth MacKenzie


 


01786 845 912




 


 


 




Stifel Nicolaus Europe Limited


 


 




Mark Young


mark.young@stifel.com


+44 20 7710 7600




Neil Winward


neil.winward@stifel.com


+44 20 7710 7600




Tom Yeadon


tom.yeadon@stifel.com


+44 20 7710 7600




 


 


 




Maitland Administration Services (Scotland) Limited


 


 




Martin Cassels


martin.cassels@maitlandgroup.co.uk


0131 550 3760




 


 


 




FTI Consulting


 


 




Dido Laurimore


TargetHealthcare@fticonsulting.com


0203 727 1000




Claire Turvey


 


 




Richard Gotla


 


 




 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PSPBRBDGSGBBGIU